Qiagen NV Cash Flow Conversion Efficiency

Latest as of March 2026: 0.030x

Qiagen NV cash flow conversion efficiency. Based on the latest financial reports, Qiagen NV (QGEN) has a cash flow conversion efficiency ratio of 0.030x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($100.63 Million) by net assets ($3.33 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Qiagen NV (1995–2025)

Cash flow conversion efficiency of Qiagen NV from 1995 to 2025. This chart illustrates how Qiagen NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View QGEN share price today for real-time trading data and today's change.

Qiagen NV Cash Flow Conversion Ratio Explained

Qiagen NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Qiagen NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qiagen NV ranked by their cash flow conversion efficiency. Also see QGEN company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Voestalpine AG
VI:VOE
0.042x
Valmont Industries Inc
NYSE:VMI
0.085x
Alexandria Real Estate Equities Inc
NYSE:ARE
0.010x
Oil India Limited
NSE:OIL
0.054x
Nemetschek AG O.N.
XETRA:NEM
0.028x
DUFRY AG UNSP.ADR/010
F:D2JA
N/A
Zhejiang Chint Electrics Co
SHG:601877
0.148x
Canadian Utilities Limited
TO:CU
0.060x

Annual Cash Flow Conversion Efficiency for Qiagen NV (1995–2025)

The table below shows the annual cash flow conversion efficiency of Qiagen NV from 1995 to 2025. Review how much free cash does Qiagen NV generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $3.78 Billion $654.33 Million 0.173x -8.27%
2024-12-31 $3.57 Billion $673.55 Million 0.189x +56.48%
2023-12-31 $3.81 Billion $459.45 Million 0.121x -41.52%
2022-12-31 $3.47 Billion $715.26 Million 0.206x -0.01%
2021-12-31 $3.10 Billion $639.00 Million 0.206x +17.28%
2020-12-31 $2.80 Billion $492.27 Million 0.176x +34.90%
2019-12-31 $2.54 Billion $330.84 Million 0.130x -4.40%
2018-12-31 $2.63 Billion $359.50 Million 0.136x +20.89%
2017-12-31 $2.54 Billion $286.78 Million 0.113x -13.86%
2016-12-31 $2.61 Billion $341.60 Million 0.131x +5.73%
2015-12-31 $2.56 Billion $317.50 Million 0.124x +14.39%
2014-12-31 $2.66 Billion $287.96 Million 0.108x +13.96%
2013-12-31 $2.72 Billion $258.96 Million 0.095x +5.77%
2012-12-31 $2.72 Billion $244.88 Million 0.090x -6.08%
2011-12-31 $2.56 Billion $244.78 Million 0.096x -5.49%
2010-12-31 $2.48 Billion $250.75 Million 0.101x +6.92%
2009-12-31 $2.29 Billion $217.00 Million 0.095x -20.41%
2008-12-31 $1.45 Billion $173.00 Million 0.119x +95.32%
2007-12-31 $1.39 Billion $84.81 Million 0.061x -66.01%
2006-12-31 $566.16 Million $101.48 Million 0.179x -11.51%
2005-12-31 $450.46 Million $91.24 Million 0.203x +50.74%
2004-12-31 $400.38 Million $53.80 Million 0.134x -29.78%
2003-12-31 $334.79 Million $64.06 Million 0.191x +37.19%
2002-12-31 $263.03 Million $36.69 Million 0.139x -48.86%
2001-12-31 $212.97 Million $58.09 Million 0.273x +15.47%
2000-12-31 $164.58 Million $38.87 Million 0.236x -16.39%
1999-12-31 $92.66 Million $26.18 Million 0.282x +78.02%
1998-12-31 $73.10 Million $11.60 Million 0.159x +0.81%
1997-12-31 $54.00 Million $8.50 Million 0.157x +83.13%
1996-12-31 $47.70 Million $4.10 Million 0.086x -73.11%
1995-12-31 $12.20 Million $3.90 Million 0.320x --

About Qiagen NV

NYSE:QGEN USA Diagnostics & Research
Market Cap
$10.38 Billion
Market Cap Rank
#2584 Global
#955 in USA
Share Price
$50.33
Change (1 day)
-1.04%
52-Week Range
$32.63 - $55.66
All Time High
$56.87
About

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technol… Read more